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SUPPLEMENTAL MATERIAL 
1. Supplemental Methods 
1A. Western blot studies 
Rats were killed using an overdose of isoflurane (Merial Animal Health Ltd., Harlow, UK). 
Brains were removed and 1 mm-thick brains sections were obtained using a brain matrix 
(Alto; World Precision Instruments, Sarasota, FL, USA). Hippocampal subregions (CA1, CA3 
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and dentate gyrus) were microdissected on ice under a microscope (Leica MZ95) and flash 
frozen in liquid nitrogen and stored at -80°C until use.  
The tissues were homogenized in lysis buffer containing 50 mM Tris, 150 mM NaCl, 5 mM 
EDTA, 1% Triton X-100 and  a protease inhibitor cocktail (Complete EDTA-free, Roche 
Applied Science, Burgess Hill, UK). The lysates were centrifuged at 1,000 x g for 15 
minutes. The supernatants were kept and rotated for 1 hour at 4°C, again centrifuged at 
20,000 x g for 15 minutes and diluted 10 times with lysis buffer. The diluted lysate was 
solubilized in Laemmli sample buffer, denaturated at 95°C and resolved on 10% 
polyacrylamide gel. Proteins in the gel were transferred to PVDF membranes (Bio-Rad, 
Hercules, CA) and western blotting was performed in PBS containing 0.2% Tween (PBS-T). 
Membranes were blocked for 1 h in PBS-T containing 5% non-fat dried milk and incubated 
overnight with primary antibody (rabbit anti-GAT-1, 1:5,000, ab426, Abcam (Cambridge, UK) 
or rabbit anti- GAT-3, 1:500, AB1574, Millipore) in PBS-T containing 1% BSA at 4°C with 
gentle agitation. After three washes, membranes were incubated for 1 hour at room 
temperature with HRP-peroxidase conjugated secondary antibody (goat anti-rabbit IgG, 
Jackson Immunoresearch Laboratories, West Grove, PA, USA). After six successive 
washes, immunoreactivity on the membranes was revealed using ECL or ECL Plus Western 
blotting detection kits (GE Healthcare Life Sciences, Little Chalfont, UK). 
1B. Immunofluorescence studies 
On the day of the experiment, rats were quickly anesthetized with isoflurane and received an 
overdose of pentobarbital (Euthatal, 200 mg/kg body weight i.p., Merial Animal Health Ltd.) 
after which they were transcardially perfused with ice-cold saline followed by 500 ml of ice-
cold 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were removed and cut 
into 50 µm-thick horizontal sections using a vibratome (Leica VT 1000S, Leica, Nussloch, 
Germany) and stored at 4°C until use. 
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Free floating sections were incubated for 1 hour in blocking solution (2% BSA, 10% 
normal goat serum (NGS), 0.2 M glycine, and 0.1% Triton X-100 in Phosphate Buffered 
Saline (PBS)) and then incubated overnight with one of the following combinations of 
primary antibodies diluted in incubation solution (0.8 % BSA, 1% NGS and 0.1 % Triton X-
100 in PBS): (a) rabbit anti-GAT-1 (1:100; AB1570, Millipore, Billerica, MA, USA) and mouse 
anti-GFAP (1:1,000; G3893, Sigma Aldrich, St. Louis, MO); (b) rabbit anti-GAT-1 and mouse 
anti-synaptophysin (1:1,000; Clone SY38, DAKO, Ely, UK); (c) rabbit anti-GAT-3 (1:50; 
AB1574, Millipore) and mouse anti-GFAP antibody; or (d) rabbit anti-GAT-3 and mouse anti-
synaptophysin. Subsequently, sections were incubated for 2 hours with the secondary 
antibodies AlexaFluor®488 anti-rabbit IgG and AlexaFluor®546 anti-mouse IgG (Invitrogen, 
Grand Island, NY, USA) diluted 1:300 in phosphate buffer. Sections were carefully rinsed 
with phosphate buffer between each step. All incubations were carried out at room 
temperature and in darkness when using the fluorescent antibodies. Sections were mounted 
onto poly-L-lysinated slides and cover slipped with Vectorshield anti-fading mounting media 
(Vector Laboratories Ltd., Burlingame, CA, USA). Sections were analyzed and images were 
taken using a Leica SP5-AOBS confocal laser scanning microscope attached to a Leica DM 
I6000 inverted epifluorescence microscope. 
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2. Figure S1
A
B
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3. Legend to Figure S1 
A) Representative western blots showing the expression of GAT-1 (left panel) and GAT-3 
(right panel) within the CA1, CA3 and dentate gyrus (DG) of the hippocampus in 3 individual 
rats (1, 2, 3).  
B) GAT-1 and GAT-3 are differentially localized in the granular cell layer of the rat dentate 
gyrus as shown by dual-labeling immunofluorescence. Confocal Z-stack images 
representing the co-localization of GABA transporters (GAT-1: B-1 and B-2, GAT-3: B-3 and 
B-4; green fluorescence) with either synaptophysin (B-1 and B-3; red fluorescence) or the 
astrocytic marker GFAP (B-2 and B-4; red fluorescence). Co-localization of immunoreactive 
molecules is indicated by a yellow color in the merged images and examples are indicated 
by white arrows. GAT-1 showed clear co-localization with synaptophysin (B-1) but not with 
GFAP (B-2). In contrast, expression of GAT-3 seems to be restricted to astrocytes (B-4). 
Pixel sizes are 90.9, 85.7, 84.5 and 105.7 nm, for figures B-1, B-2, B-3 and B-4, respectively. 
Scale bar = 10 m. 
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4. Figure S2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Legend to Figure S2 
Summary graphs showing changes in holding currents (left panel) and RMS noise (right 
panel) in the absence of TTX (see Methods in manuscript) following application of SNAP-
5114 (n=4), NNC-711 (n=3), in the presence of both drugs (n=6), and after a blockade of 
GABAA receptors by picrotoxin (n=6). One way ANOVA holding current F3,15 = 42.39, p < 
0.001; one way ANOVA RMS noise F3,15 = 52.59, p < 0.001. n.s., non significant; * p < 0.05,  
** p < 0.01 and *** p < 0.001, compared to the baseline condition (paired t-test); ## p < 0.01 
and ### p < 0.001 (unpaired t-test). ∆Ihold and ∆RMS noise values represent changes from 
the baseline condition. 
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